RESEARCH PAPER
Awareness of gastrointestinal tract malignancies among the population of Lublin province (Eastern Poland) – A cross-sectional study
 
More details
Hide details
1
Medical University, Lublin, Poland
2
Independent Public Primary Health Care, Parczew, Poland
3
Non-public Primary Health Care Facility, Józefów, Poland
4
Department of Pathology, University Medical Centre, Utrecht, The Netherlands
CORRESPONDING AUTHOR
Monika Berbecka   

Medical University of Lublin, Jaczewskiego 4, 20-089, Lublin, Poland
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Currently, malignancies are the most severe medical problems worldwide. Numerous, already known risk factors in carcinogenesis could be potentially avoided. Some cancer risk factors have been recognized and have become the targets of primary prophylaxis.

Objective:
The aim of the study was to ascertain the state of knowledge about risk factors, primary prevention and early detection of malignancies of gastrointestinal tract (GIT) in the urban and rural population of the Lublin province in Eastern Poland.

Material and methods:
The study was cross-sectional. The originally designed questionnaire was applied to the group of 1,352 patients, representatives of both the rural and urban environments of the Lublin province during random appointments with their general practitioner (GP).

Results:
The study showed low awareness of the issues connected with GIT malignancies within the studied group. The problem was particulary apparent in the rural population.

Conclusions:
In order to raise general awareness of cancer, different means should be applied in urban and rural populations. GPs and the media were found to have the leading rols in the promotion of primary prevention.

FUNDING
The study was partly supported by the Ministry of Science and Higher Education in Warsaw, Poland [Grant No. NN402423838]. The authors express their thanks to dr M. Skierucha for critical review of the manuscript.
 
REFERENCES (38)
1.
Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A, Visser O, Bray F. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major c ancers in 2018. Eur J Cancer. 2018 Nov; 103: 356–387. https://doi.org/10.1016/j.ejca....
 
2.
International Agency for Research on Cancer. Available from: http://www-dep.iarc.fr/WHOdb/W.... 2016; (access: 09.06.2019).
 
3.
Syczewska-Weber K, Rucinski P. The main challenges of Polish oncology. Public Health Rep. 2008; 123: 655–63. https://doi.org/10.1177/003335....
 
4.
Rossi S, Baili P, Capocaccia R, Caldora M, Carrani E, Minicozzi P, et al. EUROCARE-5 Working Group; EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods. Eur J Cancer. 2015 Oct; 51(15): 2104–2119. https://doi.org/10.1016/j.ejca.... Epub 2015 Sep 26. Avaliable from: https:// linkinghub.elsevier.com/retrie..., (access: 09.06.2019).
 
5.
“National Program for the Control of Cancer”, Dz.Urz.MZ.10.4.33, 2010; available from: http://bipold.mz.gov.pl/index?...; (access: 09.06.2019).
 
6.
Sapienza C, Issa JP. Diet, Nutrition, and Cancer Epigenetics. Annu Rev Nutr. 2016 Jul 17; 36: 665–81. https://doi.org/10.1146/annure....
 
7.
Milne AN, Sitarz R, Carvalho R, Carneiro F, Offerhaus GJ. Early onset gastric cancer: on the road to unraveling gastric carcinogenesis. Curr Mol Med. 2007; 7: 15–28.
 
8.
Colditz GA, Wei EK. Preventability of Cancer-The Relative Contributions of Biologic and Social and Physical Environmental Determinants of Cancer Mortality, Annu Rev Public Health. 2012 Apr; 33: 137–156. https://doi.org/10.1146/annure....
 
9.
Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC. Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol. 2009; 27: 2489–95. https://doi.org/ 10.1200/JCO.2008.20.3232.
 
10.
Jensen H, Nissen A, Vodsted P. Quality deviations in cancer diagnosis: prevalence and time to diagnosis in general practice. BJ Gen Pract. 2014 Feb; 64(619): e92–8. https://doi.org/10.3399/bjgp14....
 
11.
The Act of November 3, “National Program Against Cancer Disease-Poland 2016–2024” Dz.U. z 2015 r. Nr 208, poz. 1165. 2015. Available from: https://www.gov.pl/web/zdrowie...; (access: 09.06.2019).
 
12.
Frieden TR, Myers JE, Krauskopf MS, Farley TA. A public health approach to winning the war against cancer. Oncologist. 2008; 13: 1306–13. https://doi.org/ 10.1634/theoncologist.2008-0157.
 
13.
Bailar JC, Gornik HL. Cancer undefeated. N Engl J Med. 1997; 336: 1569–74. https://doi.org/10.1056/NEJM19....
 
14.
Central Statistical Office in Poland, Information Portal. Available from: http://stat.gov.pl/; (access: 09.06.2019).
 
15.
Poland in numbers- available from: http://www.polskawliczbach.pl/; (access: 09.06.2019).
 
16.
Binkowska-Bury M, Kruk W, Szymanska J, Marc M, Penar-Zadarko B, Wdowiak L. Psychosocial factors and health-related behavior among students from South-East Poland. Ann Agric Environ Med. 2010; 17(1): 107–13.
 
17.
Lynes K, Kazmi SA, Robery JD, Wong S, Gilbert D, Thaha MA. Public appreciation of lifestyle risk factors for colorectal cancer and awareness of bowel cancer screening: A cross-sectional study. IJ Surg. 2016, 36 (A): 312–318. https://doi.org/10.1016/j.ijsu....
 
18.
Willems B, Bracke P. Participants, Physicians or Programmes: Participants’ educational level and initiative in cancerscreening. Health Policy. 2018 Apr; 122(4): 422–430. https://doi.org/10.1016/j.heal....
 
19.
Pilecka M, Brzozowska A, Mazurkiewicz A. Programmed death receptor PD-1 as a potential target in anticancer therapy. Onkologia i Radioterapia – Medical Project, 2015; 2: 48–55.
 
20.
Van Heumen BW, Roelofs HM, Vink-Börger ME, Dekker E, Mathus-Vliegen EM, Dees J, et al. Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial. Orphanet J Rare Dis. 2013 Aug 6; 8: 118. https://doi.org/10.1186/1750-1....
 
21.
Dulai PS, Singh S, Marquez E, Khera R, Prokop LJ, Limburg PJ, et al. Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i6....
 
22.
Limoges-Gonzalez M, Al-Juburi A. Anal Intraepithelial Neoplasia. J Clin Gastroenterol. 2017 Mar; 51(3): 203–207. https://doi.org/10.1097/MCG.00....
 
23.
Dekker E, Rex DK. Advances in CRC prevention: screening and surveillance. Gastroenterology. 2018 Feb 15. pii: S0016–5085(18)30219-1. https://doi.org/10.1053/j.gast....
 
24.
Dinaux AM, Leijssen LGJ, Bordeianou LG, et al. The Influence of Screening on Outcomes of Clinically Locally Advanced Rectal Cancer. J Gastrointest Surg. 2018 Jun; 22(6): 1052–1058. https://10.1007/s11605-018-366....
 
25.
Colorectal Cancer Screening (PDQ®): Health Professional Version, Feb 2018 – available from: https://www.ncbi.nlm.nih.gov/b... (access: 09.06.2019).
 
26.
Perfors IAA, Helsper CW, Noteboom A, et al. Randomised controlled trial protocol (GRIP study): examining the effect of involvement of a general practitioner and home care oncology nurse after a cancer diagnosis on patient reported outcomes and healthcare utilization. BMC Cancer. 2018; 18: 132. https://doi.org/10.1186/s12885....
 
27.
Benton SC, Butler P, Allen K, et al. GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project. B J Cancer 2017; 116: 1551–1557. https://doi.org/10.1038/bjc.20....
 
28.
Jarbøl DE, Rasmussen S, Svendsen RP, et. al. Barriers to contacting general practice with alarm symptoms of colorectal cancer: a population-based study. Fam Pract. 2018 Jul 23; 35(4): 399–405. https://doi.org/10.1093/fampra....
 
29.
Suija K, Kordemets T, Annuk K, Kalda R. The Role of General Practitioners in Cancer Care: A Mixed Method Design. J Cancer Educ. 2016; 31: 136–141. https://doi.org/10.1007/s13187....
 
30.
Katzke VA, Kaaks R, Kühn T. Lifestyle and cancer risk. Cancer J. 2015 Mar-Apr; 21(2): 104–10. https://doi.org/10.1097/PPO.00....
 
31.
Bray F, Jemal A, Torre LA, Forman D, Vineis P. Long-Term Realism and Cost-Effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide; J Natl Cancer Inst. 2015 Dec; 107(12): djv273. https://doi.org/10.1093/jnci/d....
 
32.
Chipidza FE, Wallwork RS, Stern TA. Impact of the Doctor-Patient Relationship; Prim Care Companion CNS Disord. 2015; 17(5): 10.4088/PCC.15f01840. https://doi.org/10.4088/PCC.15....
 
33.
Seifart C, Hofmann M, Bär T, Knorrenschild JR, Seifart U. Breaking bad news–what patients want and what they get: evaluating the SPIKES protocol in Germany. Ann Oncol. 2014; 25(3): 707: 711. https://doi.org/10.1093/annonc....
 
34.
Montazeri A, Tavoli A, Mohagheghi MA, Roshan R, Tavoli Z. Disclosure of cancer diagnosis and quality of life in cancer patients: should it be the same everywhere? BMC Cancer. 2009; 9: 39. https://doi.org/10.1186/1471-2....
 
35.
STROBE Statement- available from: https://www.strobe-statement.o...; (access: 09.06.2019).
 
36.
Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, et.al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012 Jan-Feb; 62(1): 30–67. https://doi.org/10.3322/caac.2....
 
37.
Logan J, Bourassa MW. The rationale for a role for diet and nutrition in the prevention and treatment of cancer. Eur J Cancer Prev. 2018 Jul; 27(4): 406–410. https://doi.org/10.1097/CEJ.00....
 
38.
Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. American Cancer Society 2010 Nutrition and Physical Activity Guidelines Advisory Committee. CA Cancer J Clin. 2012 Jan-Feb; 62(1): 30–67. https://doi.org/10.3322/caac.2....
 
eISSN:1898-2263
ISSN:1232-1966